Search details
1.
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.
Carcinogenesis
; 41(4): 442-451, 2020 06 17.
Article
in English
| MEDLINE | ID: mdl-31586203
2.
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.
Int J Cancer
; 147(12): 3560-3573, 2020 12 15.
Article
in English
| MEDLINE | ID: mdl-32621752
3.
Transfusion of red blood cells does not impact progression-free and overall survival after surgery for ovarian cancer.
Transfusion
; 59(12): 3589-3600, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31633819
4.
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer.
Br J Cancer
; 119(9): 1060-1066, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30318511
5.
Duration of storage influences the hemoglobin rising effect of red blood cells in patients undergoing major abdominal surgery.
Transfusion
; 58(8): 1870-1880, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29665067
6.
Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
Gynecol Oncol
; 149(2): 371-380, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29530331
7.
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
Gynecol Oncol
; 149(1): 155-162, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29402501
8.
Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network.
Gynecol Obstet Invest
; 83(5): 508-514, 2018.
Article
in English
| MEDLINE | ID: mdl-28738361
9.
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology.
Genes Chromosomes Cancer
; 56(10): 758-766, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28639280
10.
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study.
Br J Cancer
; 116(10): 1287-1293, 2017 May 09.
Article
in English
| MEDLINE | ID: mdl-28350786
11.
AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
BMC Genomics
; 17(1): 643, 2016 08 16.
Article
in English
| MEDLINE | ID: mdl-27527602
12.
Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer.
Int J Cancer
; 138(3): 679-88, 2016 Feb 01.
Article
in English
| MEDLINE | ID: mdl-26311224
13.
Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma.
Gynecol Oncol
; 140(3): 494-502, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26721227
14.
A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants.
Oncologist
; 20(2): 151-8, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25601963
15.
Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium.
Mol Cancer
; 13: 67, 2014 Mar 21.
Article
in English
| MEDLINE | ID: mdl-24655477
16.
Association of myeloperoxidase with ovarian cancer.
Tumour Biol
; 35(1): 141-8, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-23893381
17.
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer.
Gynecol Oncol
; 135(3): 415-22, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25281495
18.
Interferon-stimulated gene, 15 kDa (ISG15) in ovarian high-grade serous carcinoma: prognostic impact and link to NF-κB pathway.
Int J Gynecol Pathol
; 33(1): 16-22, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24300530
19.
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.
Ann Surg Oncol
; 20(4): 1348-54, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23054114
20.
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium.
BMC Cancer
; 13: 178, 2013 Apr 03.
Article
in English
| MEDLINE | ID: mdl-23551967